Kristin M. Bompiani, Ph.D. - Publications

2012 Genetics and Genomics Duke University, Durham, NC 
Biochemistry, Molecular Biology

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Gunaratne R, Kumar S, Frederiksen JW, Stayrook S, Lohrmann JL, Perry K, Bompiani KM, Chabata CV, Thalji NK, Ho MD, Arepally G, Camire RM, Krishnaswamy S, Sullenger BA. Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass. Nature Biotechnology. PMID 29863725 DOI: 10.1038/nbt.4153  0.72
2016 Kahsai AW, Wisler JW, Lee J, Ahn S, Cahill Iii TJ, Dennison SM, Staus DP, Thomsen AR, Anasti KM, Pani B, Wingler LM, Desai H, Bompiani KM, Strachan RT, Qin X, et al. Conformationally selective RNA aptamers allosterically modulate the β2-adrenoceptor. Nature Chemical Biology. PMID 27398998 DOI: 10.1038/nchembio.2126  0.72
2016 Bompiani KM, Tsai CY, Achatz FP, Liebig JK, Howell SB. Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of cisplatin sensitivity. Metallomics : Integrated Biometal Science. 8: 951-62. PMID 27157188 DOI: 10.1039/c6mt00076b  0.72
2015 Soule EE, Bompiani KM, Woodruff RS, Sullenger BA. Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable Anticoagulant. Nucleic Acid Therapeutics. PMID 26584417 DOI: 10.1089/nat.2015.0565  0.72
2014 Bompiani KM, Dickerson TJ. High-throughput screening technologies for botulinum neurotoxins. Current Topics in Medicinal Chemistry. 14: 2062-80. PMID 25335886  0.72
2014 Bompiani KM, Lohrmann JL, Pitoc GA, Frederiksen JW, Mackensen GB, Sullenger BA. Probing the coagulation pathway with aptamers identifies combinations that synergistically inhibit blood clot formation. Chemistry & Biology. 21: 935-44. PMID 25065530 DOI: 10.1016/j.chembiol.2014.05.016  0.72
2014 Caglič D, Krutein MC, Bompiani KM, Barlow DJ, Benoni G, Pelletier JC, Reitz AB, Lairson LL, Houseknecht KL, Smith GR, Dickerson TJ. Identification of clinically viable quinolinol inhibitors of botulinum neurotoxin A light chain. Journal of Medicinal Chemistry. 57: 669-76. PMID 24387280 DOI: 10.1021/jm4012164  0.72
2013 Cagli? D, Bompiani KM, Krutein MC, ?apek P, Dickerson TJ. A high-throughput-compatible FRET-based platform for identification and characterization of botulinum neurotoxin light chain modulators. Journal of Visualized Experiments : Jove. 50908. PMID 24430674 DOI: 10.3791/50908  0.72
2012 Bompiani KM, Monroe DM, Church FC, Sullenger BA. A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity. Journal of Thrombosis and Haemostasis : Jth. 10: 870-80. PMID 22385910 DOI: 10.1111/j.1538-7836.2012.04679.x  0.72
2012 Bompiani KM, Woodruff RS, Becker RC, Nimjee SM, Sullenger BA. Antidote control of aptamer therapeutics: the road to a safer class of drug agents. Current Pharmaceutical Biotechnology. 13: 1924-34. PMID 22352726 DOI: 10.2174/138920112802273137  0.72
2012 Rangnekar A, Zhang AM, Li SS, Bompiani KM, Hansen MN, Gothelf KV, Sullenger BA, LaBean TH. Increased anticoagulant activity of thrombin-binding DNA aptamers by nanoscale organization on DNA nanostructures. Nanomedicine : Nanotechnology, Biology, and Medicine. 8: 673-81. PMID 21889476 DOI: 10.1016/j.nano.2011.08.011  0.72
2011 Ragheb D, Dalal S, Bompiani KM, Ray WK, Klemba M. Distribution and biochemical properties of an M1-family aminopeptidase in Plasmodium falciparum indicate a role in vacuolar hemoglobin catabolism. The Journal of Biological Chemistry. 286: 27255-65. PMID 21659511 DOI: 10.1074/jbc.M111.225318  0.72
2010 Hansen MN, Zhang AM, Rangnekar A, Bompiani KM, Carter JD, Gothelf KV, LaBean TH. Weave tile architecture construction strategy for DNA nanotechnology. Journal of the American Chemical Society. 132: 14481-6. PMID 20863133 DOI: 10.1021/ja104456p  0.72
2009 Nimjee SM, Oney S, Volovyk Z, Bompiani KM, Long SB, Hoffman M, Sullenger BA. Synergistic effect of aptamers that inhibit exosites 1 and 2 on thrombin. Rna (New York, N.Y.). 15: 2105-11. PMID 19846574 DOI: 10.1261/rna.1240109  0.72
2009 Oney S, Lam RT, Bompiani KM, Blake CM, Quick G, Heidel JD, Liu JY, Mack BC, Davis ME, Leong KW, Sullenger BA. Development of universal antidotes to control aptamer activity. Nature Medicine. 15: 1224-8. PMID 19801990 DOI: 10.1038/nm.1990  0.72
Show low-probability matches.